{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-344549","form_type":"8-K","ticker":"ANTX","cik":"0001880438","company_name":"AN2 Therapeutics, Inc.","filed_at":"2026-08-11T20:01:42+00:00","discovered_at":"2026-08-11T20:03:22.860382+00:00","generated_at":"2026-08-11T20:03:37.565171+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"AN2 Q2 net loss $8.2M; PV Phase 2 to start Q4 2026, Chagas Phase 2 by year-end","bullets":["Q2 2026 net loss $8.2M vs $6.5M YoY; R&D $6.0M, G&A $2.9M; cash $79.9M, runway into 2029.","Epetraborole Phase 2 (EBO-PV-201) in polycythemia vera: IND filing Q3 2026, enrollment Q4 2026, US/Australia sites.","M. abscessus Phase 2 investigator-initiated trial enrollment ongoing; topline results expected late 2027.","Chagas: positive NHP (100% parasite elimination) and Phase 1 data for AN2-502998; Phase 2 initiation planned late 2026.","Second boron-based development candidate (solid tumors) expected to advance by end of 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-344549","json":"https://secwatch.observer/filing/0001193125-26-344549.json","markdown":"https://secwatch.observer/filing/0001193125-26-344549.md","text":"https://secwatch.observer/filing/0001193125-26-344549.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526344549/0001193125-26-344549-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526344549/antx-20260811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-11T20:03:37.565171+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}